Cargando…
The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study
BACKGROUND: Multimorbidity is a growing concern for healthcare systems, with many countries experiencing demographic transition to older population profiles. Chronic kidney disease (CKD) is common but often considered in isolation. The extent and prognostic significance of its comorbidities is not w...
Autores principales: | Fraser, Simon D. S., Roderick, Paul J., May, Carl R., McIntyre, Natasha, McIntyre, Christopher, Fluck, Richard J., Shardlow, Adam, Taal, Maarten W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666158/ https://www.ncbi.nlm.nih.gov/pubmed/26620131 http://dx.doi.org/10.1186/s12882-015-0189-z |
Ejemplares similares
-
Correction to: The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study
por: Fraser, Simon D. S., et al.
Publicado: (2020) -
Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3
por: Shardlow, Adam, et al.
Publicado: (2017) -
Health-related quality of life, functional impairment and comorbidity in people with mild-to-moderate chronic kidney disease: a cross-sectional study
por: Fraser, Simon DS, et al.
Publicado: (2020) -
The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study
por: Shardlow, Adam, et al.
Publicado: (2017) -
Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort Study
por: Shardlow, Adam, et al.
Publicado: (2016)